Huaqing Wang

机构：Tianjin University of Traditional Chinese Medicine, Nankai University, Tianjin First Center Hospital, Tianjin Medical University Cancer Institute and Hospital, Tianjin Nankai Hospital, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin Medical University, Beijing University of Chemical Technology · ORCID：0000-0001-8751-110X

发表论文 94 篇 · 总被引 1409 次 · h-index 17

代表论文

• Radiation-Induced Intestinal Injury: Molecular Mechanisms and Therapeutic Status (2024 · DNA and Cell Biology · 被引 33)
• Tertiary Lymphoid Structures Gene Signature Predicts Prognosisand Immune Infiltration Analysis in Head and Neck Squamous CellCarcinoma (2024 · Current Genomics · 被引 26)
• Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma (2024 · Signal Transduction and Targeted Therapy · 被引 11)
• Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: a retrospective cohort study (2024 · Journal of Gastrointestinal Oncology · 被引 8)
• β-Sitosterol Inhibits Tumor Growth and Amplifies Rituximab Sensitivity through Acid Sphingomyelinase/Ceramide Signaling in Diffuse Large B-Cell Lymphoma (2024 · Journal of Agricultural and Food Chemistry · 被引 7)
• Norcantharidin Sensitizes Colorectal Cancer Cells to Radiotherapy via Reactive Oxygen Species–DRP1-Mediated Mitochondrial Damage (2024 · Antioxidants · 被引 7)